Navigation Links
Tackling depression in cancer patients can extend life
Date:4/10/2008

A study recommended by David Spiegel of Faculty of 1000 Medicine (www.f1000medicine.com), looks at the relationship between depression care management and survival rates in older patients. He identifies it as an important and well-conducted study of the effects of treatment of depression on survival in a primary care setting

A leading authority on mind-body interactions and professor of psychiatry and behavioural sciences at Stanford University, Spiegel evaluates the research published in the Annals of Internal Medicine, stressing the finding that Comorbid depression shortens survival time with cancer, and intervention with medication and psychotherapy can therefore extend survival among cancer patients.

The better survival rates were not seen in patients with depression and cardiovascular disease, only in those with cancer. Spiegel notes that this is surprising given the well-known link between depression and poor cardiovascular disease outcome.

He concludes, Vigorous diagnosis and treatment programs for comorbid depression in cancer patients should, based on this study, extend survival time.


'/>"/>

Contact: Jemima Tonks
jemima.tonks@f1000medicine.com
44-020-763-19933
BioMed Central
Source:Eurekalert

Page: 1

Related medicine news :

1. Tackling Triglycerides: 8 Ways to Solve a Big Fat Problem, From the Harvard Heart Letter
2. Lack of political will and the subordination of women are major barriers to tackling AIDS
3. Southern California Parents and Kids Take Healthy Steps in Tackling Childhood Obesity
4. Public Health Leaders Unveil Blueprint for Tackling Climate Change
5. Clinical depression linked to abnormal emotional brain circuits
6. Depression Taking Toll on Returning U.S. Vets
7. Damp, Moldy Homes May Cause Depression
8. Treating depression may improve recovery of heart rate variability following coronary syndromes
9. Study finds primary care depression treatment often does not follow quality guidelines
10. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
11. Depression May Be Worlds Most Disabling Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 2017 , ... The Bryant Agency, a Georgia based firm ... in the Dalton region, is working in conjunction with the GreenHouse organization in ... abuse. , The GreenHouse is headquartered in Dalton and provides a refuge for ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... assistance and financial planning services to communities in the greater Birmingham area, is ... provide resources to underprivileged young people in the region. , The Chris Hammond ...
(Date:7/21/2017)... ... , ... Hospital M&A activity slowed in the second quarter of 2017, according ... to 23 in the second quarter, up 15% from the 20 publicly announced acquisitions ... in the year-ago second quarter. Only four of the transactions disclosed a purchase price ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... grant from the C. R. Bard Foundation, Inc. to support the ... , a service available through the nonprofit home care agency. Using evidence-based methods, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce the ... July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical and ... skin cancer , and more. She graduated from the University of Florida College ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... CARLSBAD, Calif. , July 10, 2017  The ... in Boston, MA at the ... unequaled value and unparalleled access to global decision makers ... to draw 800+ life science leaders during two impactful ... Boston, and provides delegates with additional networking opportunities with ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology: